Edition:
United States

Sirona Biochem Corp (SBM.V)

SBM.V on TSX Venture Exchange

0.15CAD
11:37am EDT
Change (% chg)

$0.00 (+3.45%)
Prev Close
$0.14
Open
$0.15
Day's High
$0.15
Day's Low
$0.15
Volume
41,600
Avg. Vol
146,032
52-wk High
$0.22
52-wk Low
$0.14

Latest Key Developments (Source: Significant Developments)

Sirona Biochem says Wanbang Biopharma will formulate product in Jan 2017 to prepare for clinical trial
Thursday, 8 Dec 2016 08:00am EST 

Sirona Biochem Corp : Sirona Biochem Corp - "expect to receive one or more term sheets from interested parties before end of Q4 2016" for licensing agreement for TFC-1067 . Sirona Biochem Corp - Wanbang Biopharmaceuticals will formulate product (SGLT2 inhibitor) in January 2017 to prepare for a clinical trial . Sirona Biochem - Wanbang Biopharma will conduct additional pharmacology, toxicology study and file IND package with Chinese FDA for SGLT2 inhibitor .Sirona Biochem Corp - Valeant is aware of delays in scale-up and has not altered plans to commercialize skin lightener, TFC-849.  Full Article

More From Around the Web

BRIEF-Sirona Biochem announces management changes

* Sirona Biochem announces management changes Source text for Eikon: Further company coverage: